Sulodexide is under clinical development by Alfasigma and currently in Phase III for Venous Thromboembolism. According to GlobalData, Phase III drugs for Venous Thromboembolism have a 60% phase ...

Amesanar is indicated for chronic venous ulcers on the basis of an existing chronic venous insufficiency (CVI). Allo-APZ2 is under development for ... acute-on chronic liver failure (ACLF) and ...

Velopharyngeal insufficiency (VPI) is a speech condition that occurs when the soft palate and throat are unable to create a seal while speaking. This causes nasal speech that can make the speaker ...

Aortic Temporary occlusion of large blood vessels and/or circulatory support Invamed ICT Paravalvular Leak Closure Device Hard gel Deliverable by the delivery system Temporarily occlude and close ...

Chronic venous insufficiency manifests as a spectrum ... by the coexistence of any of the following factors: diabetes, peripheral neuropathy, arthritis, and various foot deformities.